ISTH 2022 Congress
Hemostatic Systems in Cancer, Inflammation and Immunity » Coagulation Proteins Beyond Hemostasis
Theme Navigation
- ISTH 2022 Congress
- Hemostatic Systems in Cancer, Inflammation and Immunity
- Coagulation Proteins Beyond Hemostasis
- Hemostatic Systems in Cancer, Inflammation and Immunity
-
Abstract Number: PB0726
(Factor VIII / Factor V) Ratio as a New Prognostic Marker for Decompensated Liver Cirrhosis
-
Abstract Number: PB0728
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro
-
Abstract Number: PB0730
Circulating activated protein C levels are reduced in cancer patients, a novel contribution to tumorigenesis?
-
Abstract Number: OC 28.3
Coagulation factor XII induces persistent uPAR-integrin β1 signaling promoting DNA damage and senescence in diabetic kidneys
-
Abstract Number: OC 28.5
Coagulation FXI regulates endothelial cell barrier function by inducing VE-cadherin proteolysis in an ADAM10-dependent manner
-
Abstract Number: PB0729
Development of a viral vector for hemopexin protein expression for gene therapy in disorders associated with increased levels of free extracellular heme
-
Abstract Number: OC 51.1
Direct oral anticoagulants cause placental vascular abnormalities and epigenetic reprogramming in placenta and the offspring
-
Abstract Number: OC 28.1
Factor X – Protease activated receptor-2 signaling in the regulation of diet-induced obesity
-
Abstract Number: PB0732
Fibrin Promotes Glioblastoma Progression via Focal Adhesion Kinase
-
Abstract Number: PB0733
Frequency of Factor II, Factor V Leiden and MTHFR mutations in children with cancer
-
Abstract Number: OC 66.4
Increased Endothelial Secretion and Reduced Circulatory Clearance Contribute to Elevated Plasma von Willebrand Factor Levels in Multiple Myeloma
-
Abstract Number: PB0731
Neutrophil activation markers as novel biomarkers for advanced stages of high-grade serous ovarian cancer
-
Abstract Number: VPB0737
Prevalence and Impact of Antiphospholipid Antibodies on Thrombotic Events in Ambulatory Cancer Patients
-
Abstract Number: OC 28.4
Protective Role of Plasminogen Deficiency in Non-Alcoholic Fatty Liver Disease and Glucose Dysmetabolism
-
Abstract Number: VPB0736
Prothrombin can modulate its expression in colon cancer cells
-
Abstract Number: PB0725
Role of von Willebrand factor Antigen as Non-invasive Biomarker for the Prediction of Portal Hypertensive Gastropathy in Patients with Liver Cirrhosis
-
Abstract Number: OC 66.1
The Factor XII-uPAR Axis Drives Ovarian Cancer Maintenance and Progression
-
Abstract Number: PB0727
The induction of Tregs by aPC depends on metabolic reprogramming and reduced αKG levels
-
Abstract Number: PB0735
Understanding fate of circulating von Willebrand factor following interaction with polymorphonuclear leukocytes
-
Abstract Number: PB0734
Visualization of Gliomas with Clot-binding Peptides